NMRA

Neumora Therapeutics, Inc.

Nasdaq · Biological Products, (No Diagnostic Substances) · EDGAR filings (CIK 1885522) · 3 signals · 0 setups · updated Aug 16, 2026

What the filings say Pressure ▼

First time the auditor-facing going-concern language appears: the company itself doubts it can fund 12 months.

Radar 40 (low attention) · dilution pressure low · listing risk low · governance risk elevated · runway 8.0 mo · strongest signal: New going-concern flag (Aug 14, 2026)

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

40Radar · attention score (0–100)

25Dilution pressure · financing + balance sheet

0Listing risk · exchange standards

51Governance risk · reporting, auditor, going concern

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on NMRA

Alerts

One email the morning NMRA files anything that matches your rules (types, minimum score, setups).

12-month history

Every signal and setup for NMRA back a year, not just 30 days — see how the current setup built.

Full analyst notes

What we noticed, evidence with links, what could prove us wrong, red-team caveats.

Full screener + CSV

All 985 flagged companies, same-day, sortable and exportable.

Get Pro · $18.85/mo founding rate See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

$116.8Mcash + short-term investments as of Jun 30, 2026

8.0 moestimated runway (annualized 180-day YTD operating cash flow [companyfacts])

$44.5Mstockholders' equity as of Jun 30, 2026

$63.3Mpublic float (10-K cover)

187.9Mshares outstanding as of Aug 10, 2026 · was 185.3M May 1, 2026

Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

Date	Signal	Evidence	Score
Aug 14, 2026	▼ New going-concern flag	“going concern periodic” language in 10-Q (10-Q) filed 2026-08-14 filing	37
Aug 14, 2026	· Officer/director change	8-K Item 5.02 filed 2026-08-14 (accepted 03:13 ET) filing	28
Jun 30, 2026	▼ Runway 6–12 months	~8.0 months runway: liquidity $116,834,000 as of 2026-06-30, burn $174,251,000/yr (annualized 180-day YTD operating cash flow [companyfacts]) filing	25

Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans